{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/47253405"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "Needham & Company served as exclusive financial advisor to 3D Systems on this transaction.Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT) is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat orphan and more prevalent liver and other diseases utilizing its expertise in bile acid chemistry." ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "needhamco.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/441666909"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/47253405"] } } }
